QED Trademark Information

Trademark by ImmunoPharmaceutics, Inc.

scientific research services in the field of monoclonal antibody development, protein crystallography, monoclonal antibody sequencing and three-dimensional molecular modeling

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 6/1/1992
First Use In Commerce: 6/1/1992
General Information
Word mark: QED
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
4/13/2002
Serial Number: 74451070
Filing Date: 10/26/1993
Registration Number: 1887577
Registration Date: 4/4/1995
Goods and Services: scientific research services in the field of monoclonal antibody development, protein crystallography, monoclonal antibody sequencing and three-dimensional molecular modeling
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 1/10/1995
Last Applicant/Owner:
ImmunoPharmaceutics, Inc.
San Diego 92127
Mark Drawing Code: Typeset (Words/letter/Number)
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
555 - 13th Street, N. W., Suite 701 East
Washington, DC 20004
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
4/13/2002
Correspondent Search:
Edward S. Irons is a correspondent of QED trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on